Compare · LUCY vs RXST
LUCY vs RXST
Side-by-side comparison of Innovative Eyewear Inc. (LUCY) and RxSight Inc. (RXST): market cap, price performance, sector, and recent activity on the wire.
Summary
- Both LUCY and RXST operate in Ophthalmic Goods (Health Care), so they compete in similar markets.
- RXST carries a market cap of $272.7M.
- Both names hit the wire about 3 times in the past 4 weeks.
- RXST has more recent analyst coverage (25 ratings vs 0 for LUCY).
- Company
- Innovative Eyewear Inc.
- RxSight Inc.
- Price
- $1.06+0.95%
- $7.26+0.90%
- Market cap
- -
- $272.7M
- 1M return
- -3.64%
- -
- 1Y return
- -48.79%
- -
- Industry
- Ophthalmic Goods
- Ophthalmic Goods
- Exchange
- NASDAQ
- NASDAQ
- IPO
- 2022
- 2021
- News (4w)
- 3
- 3
- Recent ratings
- 0
- 25
RxSight Inc.
RxSight, Inc., a medical technology company, develops light adjustable lens (LAL) to improve uncorrected visual acuity that can be adjusted enhance uncorrected visual acuity after cataract surgery. It also offers RxSight light delivery device, an office-based light treatment device that delivers UV light in a programmed pattern to modify the LAL based on the visual correction needed to achieve desired vision after cataract surgery. RxSight, Inc. was formerly known as Calhoun Vision, Inc. and changed its name to RxSight, Inc. in February 2017. The company was incorporated in 1997 and is based in Aliso Viejo, California.
Latest LUCY
- Innovative Eyewear, Inc. Announces Preliminary Q1 2026 Results
- Innovative Eyewear, Inc. Receives Red Dot Design Award on Lucyd Armor Smart Safety Glasses
- Innovative Eyewear, Inc. Announces New Reebok Optical Collection and Retail Placements
- Innovative Eyewear, Inc. Announces New Smart Safety Glasses and Rx Safety Partner
- Innovative Eyewear Inc. Reports Full Year 2025 Financial Results
- SEC Form 10-K filed by Innovative Eyewear Inc.
- Innovative Eyewear, Inc. Announces Q4 and Full Year 2025 Earnings Conference Call
- Innovative Eyewear, Inc. Announces New Distribution with Major European Retailer MODIVO Group
- Innovative Eyewear, Inc. Receives Notice of Patent Allowance for Smartglasses Charging Cradle
- Amendment: SEC Form SCHEDULE 13G/A filed by Innovative Eyewear Inc.
Latest RXST
- RxSight, Inc. to Report First Quarter 2026 Financial Results on May 6
- SEC Form 4 filed by Goldshleger Ilya
- RxSight Highlights 300,000 Light Adjustable Lens Implant Milestone and Strong Scientific Presence at ASCRS 2026
- RxSight, Inc. to Participate in the 25th Annual Needham Virtual Healthcare Conference
- Amendment: SEC Form SCHEDULE 13G/A filed by RxSight Inc.
- Amendment: SEC Form 8-K/A filed by RxSight Inc.
- Chief Financial Officer Wilterding Mark converted options into 20,441 shares and covered exercise/tax liability with 8,068 shares (SEC Form 4)
- Chief Customer Officer Gaines Scott converted options into 6,261 shares and covered exercise/tax liability with 2,580 shares, increasing direct ownership by 33% to 14,848 units (SEC Form 4)
- SEC Form 4 filed by Chief Operating Officer Goldshleger Ilya
- SEC Form 4 filed by Officer Weinberg Eric